LS
Lalan Singh
About Lalan Singh
Data last updated:
Lalan Singh is a Director at Ultravalue Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Ultravalue Pharmaceuticals Private Limited reported revenue of ₹9.75 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ultravalue Pharmaceuticals Private Limited U51900UP2022PTC165514 | Director | 10 Jun 2022 | 2022 | ₹9.75 Cr (FY 2024) | Active |
Board colleagues of Lalan Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Anit | 09633577 | Ultravalue Pharmaceuticals Private Limited | Director |
| Mahesh Prasad Singh | 05118394 | Ultravalue Pharmaceuticals Private Limited | Director |
| Purshottam Kant Bajpai | 07257902 | Ultravalue Pharmaceuticals Private Limited | Director |
| Rakesh Kumar | 05157232 | Ultravalue Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lalan Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lalan Singh
Lalan Singh currently holds 1 directorship: Ultravalue Pharmaceuticals Private Limited (Director, since 10 Jun 2022, revenue ₹9.75 Cr (FY 2024)).
Lalan Singh was first appointed on 10 Jun 2022 as Director at Ultravalue Pharmaceuticals Private Limited.
The current boards of Lalan Singh's companies include Amit Kumar Anit (Ultravalue Pharmaceuticals Private Limited), Mahesh Prasad Singh (Ultravalue Pharmaceuticals Private Limited), Purshottam Kant Bajpai (Ultravalue Pharmaceuticals Private Limited), Rakesh Kumar (Ultravalue Pharmaceuticals Private Limited).